/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY) today announced positive topline results from its Phase 2 signal.
Harmony Biosciences (HRMY) Announces Positive Topline Data From Phase 2 Signal Detection Study Evaluating Pitolisant In Adult Patients With Myotonic Dystrophy Type 1 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Today, SCALE AI took the stage at Canada's ALL IN event to announce investments of $21 million for nine artificial intelligence (AI) projects selected by SCALE AI as part of its AI for Healthcare Initiative to support hospital projects pioneering the deployment of AI solutions. This latest SCALE AI initiative promotes collaboration between hospitals and AI product and solutions providers across the country to innovate further and accelerate the deployment of AI in the Canadian healthcare network